A study found that a drug called golimumab preserved beta-cell function in children and young adults with newly diagnosed Type 1 diabetes, according to findings from a Phase 2 study.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/06/200616113906.htm
No comments:
Post a Comment